Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications
Author(s) -
Cihangir Erem,
Arif Hacıhasanoğlu,
Şükrü Çelik,
Ercüment Ovalı,
Halil Önder Ersöz,
Kubilay Ükinç,
Orhan Değer,
Münir Telatar
Publication year - 2004
Publication title -
medical principles and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 45
eISSN - 1423-0151
pISSN - 1011-7571
DOI - 10.1159/000081919
Subject(s) - medicine , fibrinolysis , fibrinogen , endocrinology , von willebrand factor , plasminogen activator , diabetes mellitus , diabetic retinopathy , antithrombin , coagulation , plasminogen activator inhibitor 1 , platelet , heparin
To investigate the markers of endogenous coagulation/fibrinolysis and vascular endothelial cell function, and to assess the relationships between hemostatic parameters and diabetic vascular complications in type 2 diabetic patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom